Regenxbio Analyst Price Targets - Benzinga

Regenxbio Inc

RGNXNASDAQ

Trade with Public

Trade with Public

$7.54

0.385.38%

Últ. Act.: Nov 3, 2:39 PM

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

© 2026 Benzinga | All Rights Reserved

Regenxbio Analyst Price Targets

Wall Street analyst price targets and consensus rating for Regenxbio (RGNX).

Price Target Range — 12 Quarters

Analyst Consensus — 12 Analysts

10Buy

2Hold

Consensus RatingOutperform# Analysts12Avg. Consensus PT$24Upside to Avg. PT+213.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 5, 2026	Mizuho	Graig Suvannavejh	Initiate	Outperform	$22
Aug 25, 2026	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$23→$21
Aug 25, 2026	Baird	Brian Skorney	PT Cut	Outperform	$32→$29
Aug 10, 2026	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$26→$23
Aug 7, 2026	Barclays	Eliana Merle	Downgrade	Overweight→Equal-Weight	$12
Jun 24, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$26
Jun 22, 2026	Baird	Brian Skorney	PT Raise	Outperform	$27→$32
Jun 22, 2026	Leerink Partners	Mani Foroohar	PT Raise	Outperform	$17→$18
Jun 5, 2026	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$30→$26
May 15, 2026	B of A Securities	Geoff Meacham	PT Cut	Buy	$25→$14
May 15, 2026	Barclays	Gena Wang	PT Cut	Overweight	$37→$12
Mar 9, 2026	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$32→$30
Mar 6, 2026	Morgan Stanley	Judah Frommer	PT Cut	Overweight	$18→$17
Feb 10, 2026	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$34→$32
Feb 10, 2026	Goldman Sachs	Paul Choi	PT Cut	Neutral	$14→$12
Feb 10, 2026	Morgan Stanley	Judah Frommer	PT Cut	Overweight	$25→$18
Feb 10, 2026	Chardan Capital	Daniil Gataulin	PT Cut	Buy	$52→$50
Jan 29, 2026	Chardan Capital	Daniil Gataulin	Maintained	Buy	$52
Dec 19, 2025	Stifel	Annabel Samimy	PT Raise	Buy	$40→$45
Dec 15, 2025	Leerink Partners	Mani Foroohar	PT Raise	Outperform	$16→$20

Analyst Ratings News

PRO
Mizuho Initiates Coverage On Regenxbio with Outperform Rating, Announces Price Target of $22

Mizuho analyst Graig Suvannavejh initiates coverage on Regenxbio (NASDAQ:RGNX) with a Outperform rating and announces Price Target of $22.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $21

HC Wainwright & Co. analyst Yi Chen maintains Regenxbio (NASDAQ:RGNX) with a Buy and lowers the price target from $23 to $21.

Benzinga Newsdesk

PRO
Baird Maintains Outperform on Regenxbio, Lowers Price Target to $29

Baird analyst Brian Skorney maintains Regenxbio (NASDAQ:RGNX) with a Outperform and lowers the price target from $32 to $29.

Benzinga Newsdesk

This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday

Wall Street analysts upgraded PTGX, LECO, and JHX. See analyst ratings and price targets for these stocks.

Avi Kapoor

PRO
HC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $23

HC Wainwright & Co. analyst Yi Chen maintains Regenxbio (NASDAQ:RGNX) with a Buy and lowers the price target from $26 to $23.

Benzinga Newsdesk

This Tower Semiconductor Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Friday

Wall Street analysts changed outlook on top names. For rating changes, check our analyst ratings page. See analysts' views on ADIG, TSEM and more

Avi Kapoor